Elliott B. Grossbard, Senior VP Medical Development at RIGEL PHARMACEUTICALS INC (RIGL), bought 2,000 shares at $9.68 ($19K) on 2007-05-29, disclosed to the SEC on 2007-05-29.
Open-market purchase of $19k RIGL by Senior VP Medical Development. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.